약사에 의해 탐지된 항암제 처방오류 분석
Analysis of Chemotherapy Prescribing Errors Detected by Pharmacists
0
조회
0
다운로드
4
인용
0
참고문헌
키워드
초록
Objective: The purpose of this study was to identify the type and frequency of chemotherapy-related prescribing errors and assess the pharmacist intervention in preventing potential harm. Methods: This study was performed in satellite pharmacy of oncology/hematology unit in tertiary teaching hospital from April to September, 2009. All chemotherapy prescribing errors detected by pharmacists were recorded. Frequency and characteristics of prescribing errors were analyzed. Pharmacists reviewed 28, 495 chemotherapy orders from 12,719patients during 6-month periods. Results: A total of 835 prescription errors (2.93%) in 734 patients (5.77%) were detected by pharmacists. Alkylating agents (37.6%) followed by antimetabolite (23.35%), and mitotic inhibitors (21.44%) were the most prevalent classes in which errors occurs. The most common types of error detected were incorrect dose (34%), incorrect solution (33%),incorrect route (9%) and omission errors (8%). Changes in chemotherapy order due to pharmacists’ intervention occurred in all error cases. Conclusion: Pharmacists’ intervention in reviewing chemotherapy and drug orders intercepted potential harm due to prescribing errors. The current study provided strategies for reduction of medication errors.
Abstract
Objective: The purpose of this study was to identify the type and frequency of chemotherapy-related prescribing errors and assess the pharmacist intervention in preventing potential harm. Methods: This study was performed in satellite pharmacy of oncology/hematology unit in tertiary teaching hospital from April to September, 2009. All chemotherapy prescribing errors detected by pharmacists were recorded. Frequency and characteristics of prescribing errors were analyzed. Pharmacists reviewed 28, 495 chemotherapy orders from 12,719patients during 6-month periods. Results: A total of 835 prescription errors (2.93%) in 734 patients (5.77%) were detected by pharmacists. Alkylating agents (37.6%) followed by antimetabolite (23.35%), and mitotic inhibitors (21.44%) were the most prevalent classes in which errors occurs. The most common types of error detected were incorrect dose (34%), incorrect solution (33%),incorrect route (9%) and omission errors (8%). Changes in chemotherapy order due to pharmacists’ intervention occurred in all error cases. Conclusion: Pharmacists’ intervention in reviewing chemotherapy and drug orders intercepted potential harm due to prescribing errors. The current study provided strategies for reduction of medication errors.
참고문헌 (23)
- Cohen MR, "American Pharmaceutical Association. Medication Errors", American Pharmaceutical Association, 18.16~18.17 (1999)
- Lesar TS, "Factors related to errors in medication prescribing", JAMA, 277, pp.312~317 (1997)
- Bates DW, "Incidence of adverse drug events and potential adverse drug events: implications for prevention", JAMA, 274, pp.29~34 (1995)
- Bates DW, "Incidence and preventability of adverse drug events in hospitalized patients", J Gen Intern Med, 8, pp.289~294 (1993)
- Seeley CE, "A baseline study of medication error rates at Baylor University Medical Center in preparation for implementation of a computerized physician order entry system", BUMC Proceedings, 17, pp.357~361 (2004)
- Valentin A, "Errors in administration of parenteral drugs in intensive care units: multinational prospective study", BMJ, 338, pp.b814~ (2009)
- Kohn LT, "To error is human: building a safer health system", pp.287~ (2000), National Academy Press
- Kloth DD, "Prevention of chemotherapy medication errors", Journal of Pharmacy Practice, 15, pp.17~31 (2002)
- Schulmeister L, "Preventing chemotherapy errors", The Oncologist, 11, pp.463~468 (2006)
- Leape LL, "Pharmacist participation on physician rounds and adverse drug events in the intensive care units", JAMA, 282, pp.267~270 (1999)
- Folli HL, "Medication error prevention by clinical pharmacists in two children’ hospitals", Pediatrics, 79, pp.718~722 (1987)
- Broyles JE, "Pharmacist interventions improve fluid balance in fluid restricted patients requiring parenteral nutrition", Ann Pharmacother, 25, pp.119~122 (1991)
- Estellat C, "Impact of pharmacy validation in a computerized physician order entery context", Int J Qual Health Care, 19, pp.317~325 (2007)
- Warholak TL, "of community chain pharmacists’interventions on electronic prescriptions", J Am Pharm Assoc, 49, pp.59~64 (2009)
- Phillps J, "Retrospective analysis of mortalities associated with medication errors", Am J Health Syst Pharm, 58, pp.1835~1841 (2001)
- Lustig A, "Medication error prevention by pharmacists –An Israeli solution", Pharm World Sci, 22, pp.21~25 (2000)
- Rinke ML, "Characteristics of pediatric chemotherapy medication errors in a National error reporting database", Cancer, 110, pp.186~195 (2007)
- Lewis PJ, "Prevalence, incidence and nature of prescribing errors in hospital inpatients. A systemic review", Drug Safety, 32, pp.379~389 (2009)
- Brown JN, "Effect of pharmacists on medication errors in an emergency department", Am J Health-Syst Pharm, 65(4), pp.330~333 (2008)
- Ford CD, "Study of medication errors on a community hospital oncology ward", J Oncol Pract, 2, pp.149~153 (2006)
- Gandhi TK, "Medication safety in the ambulatory chemotherapy setting", Cancer, 104, pp.2477~2483 (2005)
- Sacks GS, "Frequency and severity of harm of medication errors related to the parenteral nutrition process in a large university teaching hospital", Pharmacotherapy, 29, pp.966~974 (2009)